Search results
BIOPHEN DiXaI (Direct Xa Inhibitors)
Measurement of rivaroxaban and other factor Xa inhibitors in citrated plasma or other biological fluids. Note: BIOPHEN Heparin LRT and BIOPHEN Heparin (3 or 6) can also be used for testing direct factor Xa inhibitors (DiXaIs), such as rivaroxaban, apixaban or edoxaban. Adjusted protocols are available on demand.
BIOPHEN DTI (Direct Thrombin Inhibitors)
Assay proposed for the measurement of anti-IIa activity in research applications.
BIOPHEN Factor IX (1)
Assay proposed for the measurement of factor IX activity in research applications.
BIOPHEN Factor IX (2.5)
Assay proposed for the measurement of factor IX activity in research applications.
BIOPHEN Factor IX (6)
Assay proposed for the measurement of factor IX activity in research applications.
BIOPHEN Factor IXa
Assay proposed for the measurement of factor IXa activity in research applications.
BIOPHEN Factor VII
Assay proposed for the measurement of factor VII activity in research applications.
BIOPHEN Factor VIIa
Assay proposed for the measurement of factor VIIa activity in research applications.
BIOPHEN Factor VIII (bovine reagent R1)
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A) Follow-up of FVIII recovery in treated patients (exceptemicizumab) Factor VIII inhibitor assay in presence oemicizumab Measurement of high FVIII concentrations
BIOPHEN Factor VIII:C 2.5
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A). Follow-up of FVIII recovery in treated patients. Measurement of high FVIII concentrations.